CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 26, 2007, Pages 11008-11013

  Hosen, Naoki ^a,d   Park, Christopher Y ^a   Tatsumi, Naoya ^b   Oji, Yusuke ^b   Sugiyama, Haruo ^b   Gramatzki, Martin ^c   Krensky, Alan M ^a   Weissman, Irving L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF KIEL   (Germany)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hematopoietic stem cell

Indexed keywords

ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD96 ANTIGEN; CELL MARKER; IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL RENEWAL; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA STEM CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; BIOLOGICAL MARKERS; FLOW CYTOMETRY; GRAFT SURVIVAL; HUMANS; LEUKEMIA, MYELOID; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 34547415968     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0704271104     Document Type: Article

References (25)

1. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Nature 414:105-111.
2. Passegue E, Jamieson CMH, Allies LE, Weissman IL (2003) Proc Natl Acad Sci USA 100:11842-11849.
3. Warner JK, Wang JCY, Hope KJ, Jin L, Dick JE (2004) Oncogene 23:7164-7177.
4. Huntly BJ, Gilliland DG (2005) Nat Rev Cancer 5:311-321.
5. Weissman IL (2005) J Am Med Assoc 294:1359-1366.
6. Miyamoto T, Weissman IL, Akashi K (2000) Proc Natl Acad Sci USA 97:7521-7526.
7. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B (1992) Proc Natl Acad Sci USA 89:2804-2808.
8. Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, Meyerrose T, Rossi R, Grimes B, Rizzieri DA, et al. (2000) Leukemia 14:1777-1784.
9. Jordan CT, Guzman ML, Noble M (2006) N Engl J Med 355:1253-1261.
10. Maloney DG, Liles TM, Czerwinski DK, Waldichuk C, Rosenberg J, Grillo-Lopez A, Levy R (1994) Blood 84:2457-2466.
11. Sievers EL, Larson RA, Stadtmauer EA, Estey E, Lowenberg B, Dombret H, Karanes C, Theobald M, Bennett JM, Sherman ML, et al. (2001) J Clin Oncol 19:3244-3254.
12. Keating MJ, Flinn I, Jain V, Binet JL, Hillmen P, Byrd J, Albitar M, Brettman L, Santabarbara P, Wacker B, et al. (2002) Blood 99:3554-3561.
13. Smith MR (2003) Oncogene 22:7359-7368.
14. Kojima T, Kitamura T (1999) Nat Biotechnol 17:487-490.
15. Bonnet D, Dick JE (1997) Nat Med 3:730-737.
16. Wang PL, O'Farrell S, Clayberger C, Krensky AM (1992) J Immunol 148:2600-2608.
17. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE (1994) Nature 367:645-648.
18. Gramatzki M, Ludwig WD, Burger R, Moos P, Rohwer P, Grunert C, Sendler A, Kalden JR, Andreesen R, Henschke F, et al. (1998) Exp Hematol 26:1209-1214.
19. Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, et al. (1996) Nat Med 2:1329-1337.
20. Goldman JP, Blundell MP, Lopes L, Kinnon C, Santo JPD, Thrasher AJ (1998) Br J Haematol 103:335-342.
21. Adams GP, Weiner LM (2005) Nat Biotechnol 23:1147-1157.
22. Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M (2004) J Immunol 172:3994-3998.
23. De Tomaso AW, Nyholm SV, Palmeri KJ, Ishizuka KJ, Ludington WB, Mitchel K, Weissman IL (2005) Nature 438:454-459.
24. Blair A, Hogge DE, Ailles LE, Lansdorp PM, Sutherland HJ (1997) Blood 89:3104-3112.
25. Ailles LE, Gerhard B, Kawagoe H, Hogge DE (1999) Blood 94:1761-1772.